Orly Lipsitz Selected Research

Ketamine

1/2022	Frequency analysis of symptomatic worsening following ketamine infusions for treatment resistant depression in a real-world sample: Results from the canadian rapid treatment center of excellence.
1/2022	Do sleep changes mediate the anti-depressive and anti-suicidal response of intravenous ketamine in treatment-resistant depression?
1/2022	Sex differences in ketamine's therapeutic effects for mood disorders: A systematic review.
1/2022	Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression.
1/2022	Effectiveness of intravenous ketamine in mood disorder patients with a history of neurostimulation.
1/2022	Does body mass index predict response to intravenous ketamine treatment in adults with major depressive and bipolar disorder? Results from the Canadian Rapid Treatment Center of Excellence.
12/2021	Ketamine for psychotic depression: An overview of the glutamatergic system and ketamine's mechanisms associated with antidepressant and psychotomimetic effects.
11/2021	The meaningful change threshold as measured by the 16-item quick inventory of depressive symptomatology in adults with treatment-resistant major depressive and bipolar disorder receiving intravenous ketamine.
11/2021	Ketamine monotherapy versus adjunctive ketamine in adults with treatment-resistant depression: Results from the Canadian Rapid Treatment Centre of Excellence.
10/2021	Efficacy of ketamine and esketamine on functional outcomes in treatment-resistant depression: A systematic review.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Orly Lipsitz Research Topics

Disease

26	Treatment-Resistant Depressive Disorder 01/2022 - 01/2020
13	Major Depressive Disorder (Major Depressive Disorders) 01/2022 - 01/2020
11	Bipolar Disorder (Manic Depressive Psychosis) 01/2022 - 01/2020
9	Mood Disorders (Mood Disorder) 01/2022 - 11/2020
2	Anhedonia 01/2022 - 11/2020
2	Inflammation (Inflammations) 04/2021 - 01/2020
2	Mental Disorders (Mental Disorder) 01/2021 - 12/2020
2	Insulin Resistance 01/2021 - 01/2020
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2022
1	Psychomotor Agitation (Akathisia) 01/2022
1	Tardive Dyskinesia 12/2021
1	Dysuria 04/2021
1	Hematuria 04/2021
1	Nausea 01/2021
1	COVID-19 01/2021
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Headache (Headaches) 01/2021
1	Alcoholism (Alcohol Abuse) 01/2021
1	Weight Gain 11/2020
1	Weight Loss (Weight Reduction) 11/2020
1	Psychotic Disorders (Schizoaffective Disorder) 08/2020
1	Mania (Manias) 08/2020

Drug/Important Bio-Agent (IBA)

32	Ketamine FDA LinkGeneric 01/2022 - 01/2020
15	Antidepressive Agents (Antidepressants)IBA 01/2022 - 01/2020
5	EsketamineIBA 01/2022 - 01/2021
3	Psilocybin (Psilocibin)IBA 01/2022 - 12/2020
2	Therapeutic UsesIBA 01/2022 - 01/2021
2	N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA 01/2021 - 12/2020
2	Hallucinogens (Psychedelics)IBA 01/2021 - 12/2020
1	Antipsychotic Agents (Antipsychotics)IBA 12/2021
1	Nerve Growth Factors (Neurotrophins)IBA 10/2021
1	Pentoxifylline (Trental)FDA LinkGeneric 10/2021
1	Anesthetics (Anesthetic Agents)IBA 04/2021
1	Immunoglobulin E (IgE)IBA 04/2021
1	VortioxetineIBA 01/2021
1	Antihypertensive Agents (Antihypertensives)IBA 01/2021
1	Ibogaine (Endabuse)IBA 01/2021
1	Lysergic Acid Diethylamide (LSD)IBA 01/2021
1	Histamine (Histamine Dihydrochloride)FDA Link 11/2020
1	Serotonin (5 Hydroxytryptamine)IBA 11/2020
1	Bupropion (Wellbutrin)FDA LinkGeneric 11/2020
1	Mirtazapine (Rexer)FDA LinkGeneric 11/2020
1	Hormones (Hormone)IBA 01/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020
1	AdiponectinIBA 01/2020
1	Adenosine Diphosphate (ADP)IBA 01/2020
1	CytokinesIBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	C-Reactive ProteinIBA 01/2020

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 12/2021